Chakraborty P, Chakraborty K. Anti-fibrotic agents could be the game-changer for post-COVID-19 pulmonary fibrosis treatment. Eur J Biol Res [Internet]. 2022 Jan. 1 [cited 2024 Apr. 20];12(1):1-10. Available from: http://jbrodka.com/index.php/ejbr/article/view/1